Guidelines by areas of disease
The clinical practice guidelines we produce help drive the diagnosis and treatment of hematologic diseases. You can read about our work in this area in the guidelines initiative overview.
EHA also endorses guidelines produced by other societies. For convenience, we’ve listed these below. Please note that we’re not accepting endorsement requests until the end of 2025.
How to use this page
You can use the filters below to find guidelines that relate to specific areas of disease. This includes:
- Our published guidelines
- Guidelines that we’re still developing
- Guidelines by other societies that we’ve endorsed
If you have any questions about any of these guidelines, please email our Guidelines team.
Other ways to view these guidelines
In addition to this overview page and the EHA Guidelines app, we also have lists of published EHA guidelines that cover the following categories:
- AL Amyloidosis
- Anemia
- Bleeding and thrombosis
- Bleeding disorders
- Cardiovascular toxicity of anti-cancer treatments
- Chronic myelomonocytic leukemias (CMML)
- Infections
- Lymphomas
- Multiple myeloma
- Methemoglobinemia
- Neutropenias
You can access the latest information on resources we’ve endorsed by visiting our list of guidelines endorsed by EHA.